コンテンツへスキップ

GeneFrontier ジーンフロンティア株式会社

  • Solutions
    • Koutai Shokunin
      • Overview
      • Price
      • Flow
    • PUREfrex®
      • Overview
      • Lineup
      • Technology
    • PUREfrex® RD
      • Overview
    • Drug Discovery
      • Overview
  • Support
    • Downloads
      • Koutai Shokunin
      • PUREfrex®
      • PUREfrex® RD
    • Cases
      • Koutai Shokunin
      • PUREfrex®
      • PUREfrex® RD
    • News
      • Exhibition
      • Campaign
      • Others
    • FAQ
      • Koutai Shokunin
      • Purefrex®
      • PUREfrex® RD
  • Company
    • Intoroduction
    • Corporate Profile
    • Access
    • Partners
  • Contact
    • General Contact Form
    • Koutai Shokunin Contact Form
    • PUREfrex® Contact Form
検索 検索

日本語

  • 日本語
English

Cases

  • Home
  • Support
  • Cases
  • PUREfrex RD
  • All
  • Koutai Shokunin
  • PUREfrex®
  • PUREfrex® RD
  • New Biologics projects

    Cyclic peptides lead to New Biologics, such as highly multi-……
    PUREfrex® RD Drug Discovery
    2023
  • Small Molecule projects

    Cyclic peptides are utilized for design of small molecule. ……
    PUREfrex® RD Drug Discovery
    2023
  • Cyclic Peptide projects

    PUREfrex® RD generates various cyclic peptides for many targ……
    PUREfrex® RD Drug Discovery
    2021
  • PUREfrex® RD: the unique antibody engineering method based on Ribosome Display with PUREfrex®

    Recently, in vitro screening methods such as phage display o……
    PUREfrex® RD
    2014
  • Solutions
    • Koutai Shokunin
    • PUREfrex®
    • PUREfrex® RD
    • Drug Discovery
  • Support
    • Downloads
    • Cases
    • News
    • FAQ
  • Company
    • Intoroduction
    • Corporate Profile
    • Access
    • Partners
  • Contact
    • General Contact Form
    • Koutai Shokunin Contact Form
    • PUREfrex® Contact Form
  • Recruit
  • Privacy Policy
Copyright © 2023, GeneFrontier Corporation All rights reserved.